Insiders Veracyte, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
20.12 ^USD	-4.33%		-0.05%	-26.86%

07/05	Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M	MT
07/05	Transcript : Veracyte, Inc., Q1 2024 Earnings Call, May 07, 2024

Veracyte, Inc. Announces Retirement of John L. Bishop, A Member of the Board of Directors	14/02	CI
Veracyte, Inc. Appoints Phillip G. Febbo as Chief Scientific Officer and Chief Medical Officer, Effective 2, 2023	27/23/27	CI
Veracyte, Inc. Announces Resignation of Tina S. Nova as General Manager, Urological Cancers Effective September 4, 2023	09/23/09	CI
Insider Sell: Veracyte	25/23/25	MT
Insider Sell: Veracyte	20/23/20	MT
Insider Sell: Veracyte	22/23/22	MT
Insider Sell: Veracyte	19/23/19	MT
Eiger BioPharmaceuticals Names William Kachioff CFO, James Vollins General Counsel	13/23/13	MT
Insider Sell: Veracyte	18/23/18	MT
Insider Sell: Veracyte	03/23/03	MT
Insider Sell: Veracyte	19/23/19	MT
Insider Sell: Veracyte	13/23/13	MT
Veracyte, Inc. Announces Resignation of Giulia C. Kennedy as Global Chief Scientific Officer and Chief Medical Officer	14/22/14	CI
Insider Sell: Veracyte	06/22/06	MT
Veracyte, Inc. Names John Leite as Senior Vice President and General Manager of Pulmonology & Market Access	13/22/13	CI
Veracyte, Inc. Appoints Eliav Barr to Its Board of Directors	12/22/12	CI
Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year	27/22/27	BU
Insider Buy: Veracyte	13/22/13	MT
Veracyte, Inc. Appoints Annie Mcguire as Senior Vice President and General Counsel	28/22/28	CI
Veracyte, Inc Appoints Jonathan Wygant as Chief Accounting Officer	22/22/22	CI

No results for this search